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ABSTRACT
Introduction: Research rarely considers the
origin or history of a cancer patient’s anxiety
and/or depression, instead assuming that these
illnesses are related to the cancer experience.
The aim of this study was to compare differ-
ences in the support needs of people who have
experienced anxiety/depression as part of the
cancer experience and people who have not, as
well as between people who have experienced
episodic anxiety/depression and people who
have experienced long-term anxiety/
depression.
Methods: Twenty-one semi-structured inter-
views were conducted with people with a cur-
rent or previous diagnosis of cancer, and a
current or previous experience with anxiety
and/or depression. Participants were split into
four groups based on their history with cancer
and anxiety/depression, and an inductive the-
matic analysis was conducted to identify
themes across groups.
Results: Two superordinate themes (with three
and two subordinate themes respectively) were
found: ‘coping with cancer’ and ‘health care
system support provision’. Important differ-
ences were found across groups, with partici-
pants who had a history of anxiety/depression
that was unrelated to their cancer diagnosis
coping better with the combined burden of
cancer and anxiety/depression, experiencing
less fear of cancer recurrence, and highlighting
more positive hospital and support service
related experiences, than those whose anxiety/
depression was cancer related.
Conclusion: The origin and history of a per-
son’s anxiety/depression is important to con-
sider when determining how they might cope
with cancer, what their support needs are, and
how much support they may require.
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Depression; Needs; Support
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INTRODUCTION
Traditionally, psycho-oncology has examined
anxiety and/or depression as conditions result-
ing from the cancer experience [1]. However, not
all people with cancer develop anxiety/depres-
sion, and their levels of distress vary [2, 3]. Fur-
ther, some people have pre-existing anxiety/
depression which then becomes co-morbid with
cancer, while others experience episodes of anx-
iety/depression that occur in response to signifi-
cant life events (including the cancer diagnosis).
These examples highlight that anxiety/depres-
sion experienced by someone with cancer can
have differential aetiology. However, the role of
these origins and how they influence the cancer
experience and the support needs of people with
cancer and anxiety/depression is rarely consid-
ered in psycho-oncology research [1, 4].
The most important areas in need of support
for people with cancer include physical health
and daily living, psychological health, health
system and information, and social support [5].
Although there are several interventions aimed
at addressing these needs, a recent review has
found that such interventions generally have
limited effectiveness [6]. Further, though much
of the research and interventions for people
with cancer aim at improving distress, and one
study has specifically examined how screening
for distress might uncover unmet needs in
people with cancer [7], research so far has not
taken into account whether needs differ
according to which illness (cancer or anxiety/
depression) came first, or the causes of anxiety/
depression. It is therefore unclear whether and
how the needs of people with cancer are influ-
enced by their history with anxiety/depression.
Comparing the support needs of people with
varying histories of cancer and anxiety/depres-
sion will allow us to identify and discuss how
the potentially differing needs of people
according to their cancer and anxiety/depres-
sion history can best be addressed. For example,
those who have experienced anxiety/depression
as part of the cancer experience might differ
from those who have not, and those who have
experienced episodes of anxiety/depression in
relation to significant life events might differ
from those who have experienced long-term
anxiety/depression. Support needs may differ
between these groups, as long-term depression
tends to be clinically more serious, is more often
co-morbid with anxiety, requires more treat-
ment, and leads to poorer social and psycho-
logical outcomes and reduced well-being, than
episodic depression [8]. Examining differences
between these groups is important because
although intervention studies often take into
account psychological distress at baseline [9],
they rarely consider how a prior history of
anxiety/depression may influence intervention
effectiveness. Further, the outcomes of inter-
ventions for cancer patients with distress are
often mixed, and previous systematic and
meta-analytic reviews yielded disparate conclu-
sions that are often difficult to interpret
[4, 10, 11]. This highlights the need for more
research on how the aetiology and sequence of
cancer and mental illness may determine the
support needs of people with cancer and anxi-
ety/depression. This knowledge can form the
basis for better targeted and more effective
interventions, as well as improved access to
appropriate support services, for people with
cancer and anxiety/depression.
This study therefore aims to explicitly
examine and compare the existing supports and
needs of people with cancer and different his-
tories of anxiety/depression (e.g., episodic ver-
sus long-term) through semi-structured
interviews, allowing for insights to be gained
through thematic analysis without researcher
preconceptions. Two key questions were used to
guide this study:
1. How do different histories of anxiety/de-
pression influence the support needs of
people with cancer?
2. How can support providers and health
professionals better assist people with can-
cer and anxiety/depression based on their
history with each illness?
METHODS
All procedures performed in studies involving
human participants were in accordance with
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the ethical standards of the Tasmanian Social
Science Human Research Ethics Committee
(Reference Number: H0014664) and with the
1964 Helsinki declaration and its later amend-
ments or comparable ethical standards.
Informed consent was obtained from all indi-
vidual participants included in the study.
Participants
Twenty-one participants were considered an
appropriate sample size for this study based on
information power [12]. Information power pro-
vides clear criteria for ascertaining appropriate
sample sizes in qualitative research while address-
ing some of the limitations associated with the use
of saturation [12, 13]. The sample size for this study
was ascertained based on its neither especially
broad nor narrow aims, the inclusion of partici-
pants specific to the research aim (based on meet-
ing inclusion criteria), strong rapport and
interview dialogue between ER and participants
(due to a strong knowledge of the theoretical
background and previous experience working with
cancer patients), and the use of cross-case analysis.
Participants were recruited via self-selection
sampling through advertisements in Cancer
Council Tasmania face-to-face support groups,
local hospitals, and appropriate Facebook pages
(cancer support groups). Persons interested in
participating contacted the researcher via
phone or email and were then invited to par-
ticipate in the study upon meeting the follow-
ing inclusion criteria: over 18 years of age,
current or previous diagnosis with any type of
cancer, current or previous experience with
(diagnosed or treated for) anxiety or depression
or both anxiety and depression.
Materials
Participants completed a consent form, demo-
graphics and illness characteristics question-
naire, and the shortened version of the
Depression Anxiety Stress Scale (DASS-21; 14) to
assess the symptom severity of each negative
emotional state. An interviewer guide with
open-ended questions was used to direct each
interview (see Online Resource 1).
Procedure
Ethics approval was obtained from the Tasma-
nian Human Research Ethics Committee
(H0014664). Following recruitment and meet-
ing of recruitment criteria, participants were
invited to participate in the study. Participants
were informed of the purpose of the study, as
well as the researchers’ reasons for completing it
(to increase understanding of cancer patients’
thoughts and experiences with a view to
improving support service provision) at this
early stage. Relationships were generally not
established prior to study commencement,
though six participants were known to the
interviewer through support work with Cancer
Council Tasmania.
Face-to-face one-on-one semi-structured
interviews were conducted following comple-
tion of the consent form, demographics and
illness characteristics questionnaire, and
DASS-21 [14]. The first author conducted each
interview (ER; female PhD student with formal
training and experience in support work with
cancer patients) at a place convenient to par-
ticipants (university, Cancer Council, or par-
ticipants’ homes). Audiotaped interviews lasted
between 13 and 82 min (M = 50 min), ending
after all key topics were covered. Field notes
were not taken during interviews to maintain
rapport and trust between interviewer and par-
ticipant. Further, although participants were
not offered a chance to review transcripts or
provide feedback on identified themes, they
were given an opportunity to request to be sent
any research output or publications arising from
the research.
Analysis
This study followed the COnsolidated criteria
for REporting Qualitative research (COREQ)
Checklist [15] (see Online Resource 2). Follow-
ing verbatim transcription, transcripts were
de-identified and imported into NVivo 10 [16]
for data management and thematic analysis.
A subtle realist viewpoint guided analyses,
where the researchers’ subjective perceptions
were acknowledged while attempting to
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represent the underlying existing reality under
study [17]. An inductive thematic analysis was
conducted [18]. This approach involves a
data-driven way of identifying themes, where
data is coded without any pre-existing coding
frames or researcher preconceptions. Thematic
analysis was guided by Braun and Clarke [18],
who provide clear steps for conducting such an
analysis.
Data analysis began with data immersion (ER
transcribing interviews and reading completed
transcripts several times to familiarise with the
data). All transcripts were then coded into units
of meaning by ER using NVivo 10. Units of
meaning were used for coding, as predefined
blocks of text (lines or sentences) may inaccu-
rately reflect intended meanings of participants
and important contextual information may be
missed [19]. A second coder (JH) coded 5/21
(23.81%) interviews to ensure reliability.
Between ER and JH inter-rater agreement was
high (92.25%) and inter-rater reliability was
good (Cohen’s j = 0.664).
Based on their history with cancer and anx-
iety/depression, participants were categorised
by two authors (ER and JS) into four groups:
cancer associated with anxiety/depression AND
a history of episodic anxiety/depression or
anxiety/depression caused by cancer alone
(Group 1; ten participants); cancer associated
with anxiety/depression AND long-term anxi-
ety/depression (Group 2; six participants); can-
cer that was not associated with anxiety/
depression AND a history of episodic anxiety/
depression (Group 3; one participant); and
cancer that was not associated with anxiety/
depression AND long-term anxiety/depression
(Group 4; four participants; see Table 1). Fol-
lowing the creation of these groups, codes were
collated into potential themes, with themes
then reviewed, cross-checked for overlap,
defined, and named.
RESULTS
Demographics and Illness Characteristics
Twenty-two participants were seen, with 21
(three males, 18 females) meeting inclusion
criteria for participation (one participant had
no formal diagnosis of or treatment for anxiety/
depression). Participants were aged between 23
and 75 years (M = 50 years, SD = 18 years) and
had a current or previous cancer diagnosis, with
four participants experiencing anxiety
(19.05%), five experiencing depression
(23.81%), and 12 participants experiencing
both anxiety and depression at some point
throughout their lifespan (57.14%). The major-
ity of participants (16, 76.19%) were born in
Australia, had completed year 12 or above (18,
85.71%), were employed (six, 28.57%), retired
(six, 28.57%), or not working due to health (six,
28.57%), and were married (ten, 47.62%), in a
de-facto relationship (four, 19.05%), or single
(five, 23.81%). Participants primary cancer
diagnoses included breast (nine, 42.86%), bowel
(five, 23.81%), sarcoma (one, 4.76%), Hodgkin’s
lymphoma (one, 4.76%), non-Hodgkin’s lym-
phoma (one, 4.76%), brain (one, 4.76%), liver
(one, 4.76%), prostate (one, 4.76%), and
unknown primary (one, 4.76%). Three partici-
pants had received a second primary cancer
diagnosis (14.29%), four had received a diag-
nosis of secondary/metastatic cancer (19.05%),
16 were post-treatment (76.19%), and five were
peri-treatment (23.81%). Participants cancer
treatments included surgery (20, 95.24%),
chemotherapy (16, 76.19%), radiotherapy (12,
57.14%), hormone therapy (six, 28.57%), and
tablet medication (seven, 33.33%). Nine partic-
ipants had no other multimorbid conditions
(42.86%), nine had one other multimorbid
condition (42.86%), and three had two other
Table 1 Participant groupings based on history of cancer
and anxiety/depression
Episodic
anxiety/
depression (or
caused by cancer
alone)
Long-term
anxiety/
depression
Cancer associated
anxiety/depression
Group 1 Group 2
No cancer associated
anxiety/depression
Group 3 Group 4
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multimorbid conditions (14.29%). These
demographics and illness characteristics are
available in table form in Online Resource 3.
DASS-21
On average, anxiety scores were in the moderate
range (M = 7.43, SD = 8.80), stress scores were
in the severe range (M = 15.52, SD = 8.02), and
depression scores were in the extremely severe
range (M = 14.00, SD = 11.33), though scores
on each subscale ranged from normal to extre-
mely severe.
Thematic Analysis
Differences between the four participant groups
(see Table 1) were identified across two super-
ordinate themes, with each superordinate
theme broken into several additional subordi-
nate themes (see Fig. 1). The first superordinate
theme, ‘Coping with Cancer’, describes and
compares coping strategies, personal relation-
ships, and fear of cancer recurrence (FCR) across
participant groups. The second superordinate
theme, ‘Health Care System Support Provision’,
describes and compares hospital care and sup-
port services across participant groups. To
illustrate these key themes and highlight
important issues, quotations will be presented.
Pseudo-names have been used to preserve the
anonymity of participants.
Coping with Cancer
In general, participants in Groups 1 and 2 did
not cope as well with their cancer as partici-
pants in Groups 3 and 4. More specifically,
participants in Groups 1 and 2 required more
coping strategies and resources to cope with
their cancer, while also perceiving and describ-
ing less social support and a higher FCR, than
participants in Groups 3 and 4.
Coping Strategies Most participants in Groups
1 and 2 received formal psychological treatment
for cancer-related anxiety/depression, though
participants in Group 2 generally described this
treatment in much less detail and/or were less
likely to include this as a coping strategy for
cancer. Participants in Groups 3 and 4 reported
the use of less formal coping and self-manage-
ment strategies, such as being positive, taking
control where possible, keeping busy, and
keeping life as normal as possible, with no
treatment for cancer-related anxiety and
depression described by these participants.
I couldn’t exercise and stuff which I’d
previously done a lot. … I tried to, you
Fig. 1 Thematic map comparing support needs of people with cancer and anxiety/depression
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know sort of, walk and stuff rather than
running, which I couldn’t do a whole lot,
but I could do some. Um, and a lot of it was
just getting support from other people as
well. (ER: Mmhm.) You know, friends and
family and that kind of stuff. Um, and just,
like a big thing for me was not thinking
about it constantly. So doing, keeping my
mind busy. (Dominic, Group 4)
With regard to support groups specifically,
eight of ten people in Group 1, and four out of
five people in Group 2, attended a support
group for cancer-related support. The partici-
pants in Groups 3 and 4 did not attend a
cancer-related support group. The majority of
participants attending support groups found
them highly beneficial.
Personal Relationships For participants in
Group 1, strong social support was important,
with participants describing how their cancer
diagnosis strengthened some relationships but
led to the loss of others (most often friend-
ships). Cancer was sometimes described as
changing the individual, and therefore chang-
ing their relationships. Although some partici-
pants in Group 2 described strengthened
relationships with their partner or spouse, the
majority of these participants described losing
friendships and feeling isolated, with less posi-
tive social support mentioned overall.
I had a… friend the other day, a month or
two ago I sent her a message and she asked
me how I was and I just text her back say-
ing I felt like crap and I was angry and
everything, and you know you don’t hear
from them for a month. So you’ve got to be
careful about what you say otherwise…
(ER: Mm.) people just walk away or they
just stay away for a, you know, yeah.
(Rosalina, Group 2)
In contrast, participants in Groups 3 and 4
described strong social support and personal
relationships, with no loss of relationships or
support from loved ones described.
Fear of Cancer Recurrence (FCR) FCR was
experienced by participants in Groups 1 and
2, particularly when waiting for test results
and when experiencing physiological symp-
toms that could be a sign of recurrence.
However, only participants in Group 1 expe-
rienced highly maladaptive FCR post cancer
treatment, which was described as occurring
once they had time to process what had
happened to them.
It wasn’t until after, well after 12 months
that I really … started to feel the effects of
anxiety and stuff. (ER: Mm.). When the
oncologist visits dropped off, when you
didn’t need to see a surgeon again. …
When chemo finished … So that’s when it
started to mess with me. (Freya, Group 1)
If I started to feel an ache or pain some-
where … I would get that focused on it I’d
physically make, make myself … sick, and
I’d, you know, I’d feel worse than I was,
you know, I’d have tingly feelings and all
sorts of weird feelings that I thought ‘‘well
I’m going to die’’ or something… (Eve,
Group 1).
Participants in Groups 3 and 4 were much
less concerned about FCR, with minor worry
occurring when awaiting test results and when
thinking about the possibility that they may
miss symptoms of a recurrence.
Health Care System Support Provision
In general, participants in Groups 2 and 4
described experiencing good support from the
hospital and appropriate integration with sup-
port services, while participants in Group 1
described a lack of support and information
from the hospital and a lack of integration
with appropriate support services. The partici-
pant in Group 3 made no specific comments
regarding the hospital system or use of support
services.
Hospital Care Participants in Group 1 gener-
ally described a lack of support and information
from the hospital with regard to mental health
and support services (though some participants
felt adequately supported). This was particularly
highlighted by participants at the post-treat-
ment stage.
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It’s a business … getting the cancer sorted
out, and getting the cancer over with, as far
as the hospital and all that is concerned.
(ER: Mm.). So, and it was like, once it
stopped it was like ‘‘ah, what now?’’ … I
said to my psychologist today, ‘‘It was
like… the treatment should only be start-
ing now…’’ (Sienna, Group 1)
In contrast, participants in Groups 2 and 4
felt that the hospital system was mostly good,
with less needs described.
I went Private, and they were brilliant. …
They’d give you this and they’d give you
that, and I didn’t take any of it, because
well why, there was people going to be
worse off than me. (Quinn, Group 4)
In general, interviews suggested that those
with no prior support or treatment in place for
anxiety/depression required more support from
the hospital than those with long-term and/or
previous mental illness experiences.
Support Services A lack of integration with
appropriate support services for people with
cancer, a lack of information, and few links with
counselling or psychological support services,
were described by multiple participants in
Group 1. In particular, doctors (and the hospital
system) were often described as failing to link
their patients with appropriate support services.
I don’t know what it would be like for
anybody who, um, doesn’t have support.
… cause the Doctor didn’t, nobody sort of
said ‘‘do you want counselling?’’. … there
was no offer of counselling. … Even
nobody mentioned the Support Group.
(Bella, Group 1)
Doctors need to be more responsible, more
proactive… and stop being this sausage
factory of putting people through as
quickly as you possible.… And I think a lot
of people probably find it more difficult
after treatment has finished, because
there’s nothing.… And… the lack of links
with people that are integrative medicine
specialists, like um homoeopathic, ah
naturopaths, physio … psychologists.
There’s just no central link to the whole
thing. (Bianca, Group 1)
In contrast, participants in Group 2 (bar one)
and Group 4 perceived solid links with support
services, though some of these participants had
links with mental health services already in
place prior to their cancer diagnosis.
DISCUSSION
This qualitative study aimed to compare and
examine the existing supports and needs of
people with cancer and different histories of
depression/anxiety. Our findings suggest that a
person’s support needs may differ based on
their history of coping with anxiety/depression
premorbid to their cancer diagnosis. More
specifically, we found that participants with
anxiety/depression associated with cancer (no
matter the origin or history of their anxiety/
depression) were much more likely to access
formal coping strategies such as psychological
treatment for cancer-related anxiety/depres-
sion, attend cancer support groups, lose per-
sonal relationships because of their cancer, and
experience severe maladaptive FCR, than par-
ticipants with anxiety/depression not associated
with cancer (no matter the origin or history of
their anxiety/depression). Our results also
found that participants with episodic or
cancer-related anxiety/depression felt less well
supported by the hospital system and experi-
enced less links with support services than par-
ticipants with long-term anxiety/depression.
Many of the participants in this study had a
vulnerability for experiencing anxiety/depres-
sion associated with their cancer due to their
history of long-term anxiety/depression [20].
Interestingly, however, only some of these par-
ticipants experienced cancer-related anxiety/
depression (Group 2), with these same partici-
pants also demonstrating poorer coping, need-
ing more anxiety/depression treatment, and
experiencing worse FCR. To better understand
why this might have occurred, it is important to
consider how and why those with a premorbid
history of long-term anxiety/depression and
anxiety/depression in response to their cancer
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(Group 2) might differ from those with a sim-
ilar history who did not experience any
cancer-related anxiety/depression (Group 4).
Participants in Group 2 were generally younger
than those in Group 4, had an average of one
additional chronic illness per person (whereas
only one participant in Group 4 had an addi-
tional chronic illness), reported they received
more misinformation and misdiagnoses from
health professionals, described less positive
social support interactions, and perceived
more, and more severe, cancer-related psy-
chosocial consequences. This is in line with
previous research that suggests that cancer
patients who are younger [21–23], have addi-
tional chronic illnesses [24, 25], less social
support [26, 27], and more negative illness
representations [28], are more likely to experi-
ence higher levels of distress. This suggests that
together with these potential risk factors, peo-
ple who also have a history of long-term anx-
iety/depression and who have not developed
coping strategies to manage these issues might
be at risk to develop cancer-related anxiety/
depression, and therefore may be more at need
for support to prevent or decrease such anxi-
ety/depression.
Participants with episodic or cancer-related
anxiety/depression (Group 1) often felt less
supported by the hospital system and experi-
enced less access to appropriate support and
mental health services than participants with
long-term anxiety/depression (Groups 2 and
4). Our findings suggest that this was likely due
to a lack of prior exposure to mental health and
support services, as participants with previous
or existing links with such services required
less hospital support and service access. One
other potential explanation for this pattern of
results lies with the setting for our study, a
regional area of Australia [29] with no
cancer-specific hospitals, cancer centres, and a
lack of individualised services and tailored
support (particularly psychological services).
Research suggests that people in rural/regional
settings often experience worse outcomes,
limited access to tailored cancer-specific hos-
pital care, a lack of psychological support, and
few links and referrals to other key support
services [30, 31].
Implications
Our study suggests that a person’s history of
anxiety/depression may influence how they
cope with their cancer experience. In terms of
distress trajectories in cancer patients
[2, 3, 21, 32], our findings suggest that those
who have a history of anxiety/depression that is
unrelated to cancer might be better able to cope
with the combined burden resulting from both
the mental and physical illness than those
whose anxiety/depression is related to cancer.
The knowledge that inexperience in coping
with anxiety/depression might place a person at
risk of a trajectory of chronic distress post can-
cer could inform targeted implementation of
appropriate resources and services for people at
risk. However, more research is needed to
determine which facets of a person’s anxiety/
depression history might be most important in
predicting such trajectories. Coping repertoire
and skills to manage psychological distress
would be particularly worthy of exploration.
In terms of service provision, our study is in
line with previous research [31, 33] and suggests
a need for patients to receive additional support
and information from hospitals, as well as
referrals to external mental health and support
services where required. However, hospitals
often lack the resources to implement such
changes, particularly in rural/regional areas.
This study suggests that these limited resources
are best directed towards increasing informa-
tion and links with support services for people
with cancer-related anxiety/depression, rather
than for those who report coping well with a
history of long-term anxiety/depression. This is
because the latter group often already have
existing support systems in place, while people
with cancer related anxiety/depression are dis-
tressed, have less social support, and experience
more severe FCR. For the same reasons it is also
suggested that health professionals recommend
the use of appropriate support services (includ-
ing support groups) to people with cancer-re-
lated anxiety/depression. Our findings
highlight the importance of investigating a
cancer patient’s history of anxiety/depression to
determine how much support they may (or may
not) require.
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Limitations
Although we attempted to differentiate
between people with episodic anxiety/depres-
sion and people with long-term anxiety/de-
pression, no clinical diagnostic measures or
criteria were used to assess this during the
interview process. Instead, two researchers (ER
and JS—a clinical psychologist) placed partici-
pants into groups based on participant data
(demographic and interview). Participants
were assigned to groups based upon consider-
ation of their reported family history of psy-
chological disorders, psychological responses
to past significant life events and premorbid
experience of anxiety/depression generally, as
well as their reports of their response to their
cancer experience.
Due to the widely varied cancer types,
cancer stages, and treatment types, experi-
enced by our sample, more consensus could
potentially have been found with the use of a
more focused sample, such as the inclusion of
participants who only have bowel cancer or
early-stage disease (Stage 1). Conversely, a
more diverse sample may have led to addi-
tional insights. As our sample provided both
overlapping and unique representations
across groups, a good balance between
specificity and diversity appears to have been
achieved. However, as only one participant
had episodic anxiety/depression that was not
related to cancer (Group 3), results from this
specific participant category should not be
generalised to others in similar situations.
Furthermore, given its small sample size and
exploratory nature, caution must be taken
before generalising any result from this
study.
CONCLUSIONS
In conclusion, our study has highlighted the
need for both researchers and health profes-
sionals to give more consideration to the origin
and history of a person’s anxiety/depression in
order to determine how they might cope with
cancer, their support needs, and the amount of
support they may require.
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